Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Neurotrope, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R21.htm
10-Q - FORM 10-Q FOR 10-31-2012 - Neurotrope, Inc.form_10-q.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Neurotrope, Inc.R18.htm
EX-31 - RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER - Neurotrope, Inc.ex_31-2.htm
EX-31 - RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Neurotrope, Inc.ex_31-1.htm
EX-32 - SECTION 1350 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER - Neurotrope, Inc.ex_32-1.htm
v2.4.0.6
STOCKHOLDERS' EQUITY
9 Months Ended
Oct. 31, 2012
STOCKHOLDERS? EQUITY [Abstract]  
STOCKHOLDERS' EQUITY

NOTE 4. STOCKHOLDERS' EQUITY


Preferred Stock


As of October 31, 2012, the Company has no Preferred Shares authorized, with none issued nor outstanding.


Common Stock


On January 11, 2011, the Company issued 9,000,000 of its $0.0001 par value common stock for $8,000 cash and $1,000 in a stock subscription receivable to the founder of the Company. The issuance of the shares was made to the sole officer and director of the Company and an individual who is a sophisticated and accredited investor, therefore, the issuance was exempt from registration of the Securities Act of 1933 by reason of Section 4 (2) of that Act.


On June 24, 2011, the Company sold 1,200,000 shares of common stock, $0.0001 par value for $12,000. These shares were registered with the SEC on Form S-1 which was declared effective by the SEC on May 13, 2011.


As of October 31, 2012, there are 300,000,000 Common Shares at $0.0001 par value, authorized with 10,200,000 issued and outstanding.